Vykat XR (diazoxide choline extended-release tablets) — Medica
Prader-Willi syndrome
Initial criteria
- Patient is age ≥ 4 years
- Diagnosis of Prader-Willi syndrome has been established by identification of abnormal DNA methylation of chromosome 15q11.2Q13
- Patient has hyperphagia
- Medication has been prescribed by or in consultation with an endocrinologist
Approval duration
1 year